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Abstract
The food industry is constantly striving to develop new products to fulfil the ever changing demands of
consumers and the strict requirements of regulatory agencies. For foods based on microbial fermentation, this
pushes the boundaries of microbial performance and requires the constant development of new starter cultures
with novel properties. Since the use of ingredients in the food industry is tightly regulated and under close
scrutiny by consumers, the use of recombinant DNA technology to improve microbial performance is currently not
an option. As a result, the focus for improving strains for microbial fermentation is on classical strain improvement
methods. Here we review the use of these techniques to improve the functionality of lactic acid bacteria starter
cultures for application in industrial-scale food production. Methods will be described for improving the
bacteriophage resistance of specific strains, improving their texture forming ability, increasing their tolerance to
stress and modulating both the amount and identity of acids produced during fermentation. In addition,
approaches to eliminating undesirable properties will be described. Techniques include random mutagenesis,
directed evolution and dominant selection schemes.
Introduction
Lactic acid bacteria (LABs) are industrially important
organisms used for the production of dairy products like
yoghurt, cheese, buttermilk and kefir. Apart from fer-
menting milk, LABs are also used to ferment vegetables,
meat, fish and cereals. Finally, LABs play an important
role in the production of alcoholic beverages [1]. Species
used for these applications typically belong to the genera
Lactococcus, Streptococcus, Pediococcus, Oenococccus,
Leuconostoc or Lactobacillus and have been isolated
from natural habitats like plants, or fermented foods like
dairy and meat products [2,3]. Apart from having a pre-
servative effect by inhibiting the growth of spoilage
microorganisms through the production of organic acids
and consumption of nutrients, LABs also improve orga-
noleptic properties of the product by producing metabo-
lites that can enhance taste and texture [2]. The global
dairy industry is constantly exploring new ways to
improve products to fulfil consumers’ demand for
improved taste and texture or the reduction of additives,
sugar, fat or overall calorie content. This pushes the
boundaries of microbial performance and requires the
constant development of new starter cultures with novel
properties.
Progress made in the last decade in the field of labora-
tory automation and high throughput screening of
microorganisms has significantly reduced the effort
required to screen large collections for specific traits [4].
Wild type strains may have properties unique to the
industry, but to fully exploit their potential, specific
improvements are often required. In other cases it might
be needed to reduce or eliminate an unwanted property.
In addition, it can be of interest to improve strains which
already have established industrial applicability. Recombi-
nant DNA technology, due to its precision and versatility,
would be an ideal technology to use to improve microbial
performance were it not for restrictive food legislation* Correspondence: dkpde@chr-hansen.comInnovation, Chr Hansen A/S, 10-12 Bøge Allé, DK2970, Hørsholm, Denmark
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and consumer acceptance issues for genetically modified
food ingredients. Thus, all efforts to improve strains for
industrial application are, today, based on natural strate-
gies for strain improvement (i.e. without the use of
recombinant DNA technology) such as random muta-
genesis, directed evolution and dominant selection.
Random mutagenesis (classical strain improvement) has
been used extensively in the food industry [5,6]. This
approach is based on the introduction of random mutations
into the genome of interest, characterization of a large sub-
set of variants, and selection of strains with the desired prop-
erty for further use. Despite many successes, the method is
generally hampered by the fact that, apart from the desired
mutation, many unintended mutations which could have a
negative impact on performance are introduced [7].
Directed evolution (or adaptive evolution) is a techni-
que in which a strain is slowly adapted to certain
growth conditions reflecting an application parameter
[8,9]. In this case the population is enriched for strains
with the desired property but, here too, there is a risk of
accumulation of unintended mutations (reviewed by
Barrick and Lenski [10]).
Dominant selection is based on designing a selection
scheme in which only strains with the desired property
can grow [11]. Success of such a method requires con-
siderable insight into microbial physiology. If the selec-
tion is powerful enough, strains with single mutations
can be obtained without using mutagenic agents.
Furthermore, natural mechanisms like bacteriophage
transduction, natural competence and conjugation can
be mentioned as additional useful approaches since
these are specifically excluded from the European
Union’s definition of recombinant DNA techniques pro-
vided that none of the strains involved are genetically
modified organisms [12].
In this review we will illustrate the use of the above-
mentioned methods with examples from the literature
and our own laboratories and elaborate on the impor-
tance of natural strain improvement techniques (see
Table 1 & Figure 1 for an overview). Focus will be on
Lactococcus, Streptococcus and Lactobacillus primarily
used for dairy fermentations.
Improving bacteriophage resistance
The prevention of bacteriophage attack is one of the
most important challenges in dairy fermentations.
Although naturally occurring bacteriophage resistance
mechanisms are present in LABs, it is necessary to con-
tinuously improve bacteriophage resistance due to the
high adaptability and diversity of bacteriophages [13,14].
Many bacteriophage infections can be prevented by
using a culture replacement or rotation system based on
LABs belonging to different bacteriophage sensitivity
groups. Here we focus on Lactococcus lactis due to their
importance and high frequency of use in dairy fermenta-
tions. Several approaches for making bacteriophage
resistant mutants of L. lactis are described below. These
include refinement of traditional methods like the isola-
tion of spontaneous bacteriophage resistant mutants,
conjugative transfer of bacteriophage resistance plas-
mids, as well as a novel approach based on understand-
ing the basic biology of bacteriophage infection.
Bacteriophage receptors
The Lactococcus PIP protein (Phage Infection Protein)
[15], encoded by the pip gene, is the receptor for bacter-
iophages of the prolate-headed c2 species and was
believed to be used by all c2 bacteriophages [16]. While
generating c2-resistant mutants of industrial strains of
L. lactis using the pGhost9:ISS1 integration system [17]
we found bacteriophage resistant mutants which did not
contain an ISS1 integration in the pip gene. Instead, the
integration was found to be in the yjaE gene, encoding
a protein of unknown function [18]. The yjaE gene
shows only 22% identity to the pip gene and is predicted
to encode a putative ABC-2-like protein with six mem-
brane-spanning regions with N- & C-terminal phage
infection protein domains (IPR017500 and IPR17501)
and several extended heptad repeats (TIGR03057).
Although yjaE has a domain with high similarity to the
pip phage infection domain, the low degree of identity
makes it clear that YjaE is a unique cellular component.
Generation of gene disruption mutants confirmed that
inactivation of the yjaE gene renders strains completely
resistant to a number of bacteriophages of the c2 species
as well as to two bacteriophages of the 936 species
(Table 2). Bacteriophages that require YjaE for infection
(CHPC3, CHPC24, CHL92, bil67) are not affected by
disruption of the pip gene, and bacteriophages which
require the PIP protein (CHPC180, c2) can still infect
yjaE mutants. Thus, the two best characterized type c2
bacteriophages, c2 and bIL67 [19], use different recep-
tors: c2 uses PIP and bIL67 uses YjaE.
We isolated spontaneous bacteriophage resistant
mutants of five different industrial L. lactis strains by chal-
lenging with different bacteriophages using the YjaE-
receptor and found that all resistant mutants investigated
had mutations within the yjaE gene. Out of 21 bacterioph-
age resistant mutants, 18 strains had single nucleotide
changes generating premature stop codons upstream of
the membrane-spanning regions and resulting in a trun-
cated protein. The three remaining mutants had deletions
within the membrane anchoring region, the promoter
region or the external loop. To date, we have not observed
bacteriophage using the YjaE-receptor being able to over-
come the resistance of YjaE deficient strains. Importantly,
the inactivation of the yjaE gene does not affect the acidifi-
cation profile of industrial L. lactis strains. This method is
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thus ideal for generating new bacteriophage resistant star-
ter cultures without compromising the performance of the
culture during application [18].
Conjugation
Improvement of bacteriophage resistance by conjugation
is frequently described in the literature, especially for
L. lactis, where many bacteriophage resistance systems
are localized on plasmids [20]. The bacteriophage resis-
tance of L. lactis CHCC1915 and CHCC1916 was
improved by conjugative transfer of the bacteriophage
resistance plasmid pCI1750 from L. lactis UC653 har-
boring the resistance system AbiG [21]. This abortive
infection (Abi) mechanism is encoded by two genes,
abiGi and abiGii, conferring resistance to bacterio-
phages of the 936 species, and partial resistance to c2
species bacteriophages [22]. For mating experiments, a
lactose negative derivative (MG1363 containing
pCI1750) was used as plasmid donor, and transconju-
gants were selected by challenging with bacteriophages
Table 1 Overview of methods described in this review.
Method used Advantages Disadvantages Topic Aim
Random
mutagenesis
Little knowledge required.
Especially useful for elimination of specific
characteristics where direct selection is not
possible.
Use of dangerous chemicals.
Mutation bias and hot spots.
Second site mutations will be
created.
Requires screening of a large
number of survivors.
Pyrimidine auxotrophy Bacteriophage
resistance
Elimination of antibiotic
resistance
Eliminating
unwanted
property
Elimination of citrate metabolism Eliminating
unwanted
property
Urease negative mutants of S.
thermophilus
Eliminating
unwanted
property
Lactobacillus strains with low
post acidification
Improving
product stability
Directed
evolution
Little knowledge required.
Especially useful for complex phenotypes.
Mutagens normally not required.
Multiple mutations may occur.
May require complex
experimental setups.
Slow process requiring long
time frames.
Selection is at population level,
isolated strains must be
characterized.
Increasing the growth yield
during fermentation
Increased
efficiency in
culture production
Dominant
selection
Mutagens not required.
Often results in a single mutation.
Requires considerable insight
into physiology of the cell.
Analogues may be toxic to
humans.
Bacteriophage receptors Bacteriophage
resistance
Conjugation Bacteriophage
resistance
Modifying bacterial cell surfaces Improving texture
Optimizing the metabolic
pathway of EPS
Improving texture
Bacteriophage resistant mutants Improving texture
Lactobacillus strains with
improved ethanol or bile
tolerance
Improving survival
and efficacy
Lb. helveticus producing succinate Improving flavor
Altering acidification properties
by adapting the carbohydrate
metabolism
Overcoming effect
of a mutation
Recombinant
DNA
technology
Extremely accurate targeted methods. Consumer acceptance.
Regulatory approval.
Can be difficult to apply to
industrial strains.
Potentially all of the above Potentially all of
the above
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inhibiting the recipient followed by plating on lactose
indicator agar plates. Transconjugants of CHCC1915
and CHCC1916 have been on the market for more than
20 years and are still performing well, although several
bacteriophage have been isolated which are unaffected
by the AbiG resistance system.
Figure 1 Schematic representation of various classical strain improvement targets of LABs. A cross (X) highlights the position of
mutations or effect of mutations as described in the text.
Table 2 Bacteriophage sensitivity of yjaE and pip mutants.
Phage species IL1403 IL1403
ΔyjaE
GMO
IL1403
ΔyjaE
spont.
IL1403
Δpip
GMO
CHCC
7552
CHCC
7552
ΔyjaE
GMO
CHCC
7552
ΔyjaE
spont.
CHPC3 c2 + - - + + - -
CHPC24 c2 + - - + + - -
CHPC180 c2 + + + - - - -
CHL92 c2 + - - + + - -
bIL67 c2 + - - + - - -
c2 c2 + + + - - - -
CHPC234 936 - - - - + - -
Legend table 2:
+ : lysis by bacteriophage; - : no lysis by bacteriophage
GMO: produced with recombinant DNA technology
spont.: spontaneous mutant generated by challenge with bacteriophage requiring YjaE (e.g. CHPC24).
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Pyrimidine auxotrophy
In contrast to the previous examples where bacterioph-
age resistance is not established for every bacteriophage
attacking a certain strain, it is possible to develop com-
pletely resistant mutants by abolishing bacteriophage
DNA replication [23,24]. Thymidylate synthase, encoded
by the thyA gene, is essential for the de novo synthesis of
dTTP. Since milk is devoid of thymidine, replication of
DNA, including DNA from an infecting bacteriophage, is
abolished in thyA mutants. MBP71, a thyA mutant of
L. lactis CHCC373 with a 42-bp deletion at the beginning
of the thyA gene shows complete resistance towards nine
bacteriophages from the 936 and P335 species. Because
thyA mutants are still able to synthesize RNA and
thereby also proteins, mutants are still metabolically
active. Since cell division does not occur, it is necessary
to increase the inoculation rate to reach an acidification
activity similar to that of the wild type strain [23].
MBP71 was created using recombinant DNA technology
and exclusively used for proof-of-concept. Mutagenesis
and screening for pyrimidine auxotrophy has subse-
quently been used to obtain variants of industrial strains
of L. lactis and S. thermophilus suitable for inclusion in
starter cultures. No bacteriophage variants that overcome
this resistance mechanism have been discovered to date.
Improving texture of fermented milk
Pectins and starch are often used to create the desired
texture in fermented milk products. These additives can,
however, be rendered unnecessary through development
of LABs which create the desired texture. Especially the
production of extracellular polysaccharides (EPS) has
been in focus since EPS is known to contribute to the
texture of fermented milks [25]. Here we describe several
natural strain improvement methods to improve the abil-
ity of LABs to texturize fermented milk.
Modifying bacterial cell surfaces
The bacterial cell surface is in direct contact with the
external environment and is expected to be involved in
binding of environmental components and formation of
texture in milk during fermentation. EPS production has
previously been found to be highly strain dependent and
strongly correlated to the Streptococcus thermophilus gen-
otype and especially to the genetic content of the eps gene
cluster [26]. Texture formation is, apart from EPS [27],
also affected by other bacterial cell surface components
[28,29]. The structure and function of the cell surface of
lactic acid bacteria has recently been reviewed [30].
To further exploit the role of the cell surface in the for-
mation of texture in fermented milk, we applied a domi-
nant selection strategy to isolate mutants with cell surface
alterations. Selection was based on resistance to com-
pounds interfering with the biosynthesis of cell surface
components; viz. D-cycloserine (D-4-amino-isoxazolidone)
and ampicillin. D-cycloserine is an antibiotic which inhi-
bits enzymes involved in D-alanine metabolism and can
cause cell lysis [31,32]. Ampicillin is an antibiotic which
inhibits the transpeptidase responsible for crosslinking
peptidoglycan and can also cause cell lysis [33]. Mutants
of Lactobacillus delbrueckii subsp. bulgaricus which are
resistant to either D-cycloserine or ampicillin are readily
obtained. Some of these show reduced whey syneresis
after acidification of milk and improved texturizing prop-
erties as determined by rheology measurement [14]. Preli-
minary experiments show that these mutants have
changes in their cell surfaces which affect their interac-
tions with the external environment.
Optimizing the metabolic pathway of EPS
Most strains of S. thermophilus are unable to grow on
galactose as sole carbon source in spite of the presence of
intact genes encoding the required enzymes. Increased
EPS production in S. thermophilus was observed follow-
ing enhancement of the activity of enzymes in the galac-
tose metabolic pathway (e.g. phosphoglucomutase and
glucose-1-phosphate uridylyltransferase) by genetic
manipulation [34,35]. Also, production of EPS by ropy
S. thermophilus strains was increased through genetically
targeted enhancement of galactokinase activity. However,
combining such a mutant with a Lb. delbrueckii subsp.
bulgaricus strain for yoghurt production did not result in
significant overproduction of EPS, and the texturizing
properties of the yoghurt were not improved [36].
Improvement of the rheological parameters of yoghurt by
modifying enzymatic activity in the galactose metabolic
pathway without the use of recombinant DNA techni-
ques has not been reported.
S. thermophilus CHCC6008 is used extensively in the
dairy industry because of its ability to texturize fermented
milk. Strain CHCC11379 was isolated as a spontaneous
galactose positive mutant of CHCC6008 as described in
the section describing dominant selection. The ability of
CHCC11379 to texturize fermented milk was increased
by 10%, measured as shear stress, compared to its parent
CHCC6008 [28]. Analysis of the galactose operon of
CHCC11379 revealed a G to A mutation within the -10
position of the galK promoter resulting in a perfect
“TATAAT” Pribnow box [37]. This optimized Pribnow
box increased transcription of the genes from the galac-
tose operon (galK, galT, galE, and galM) 2.5 to 3.7-fold.
The amount of excreted EPS during milk fermentation
was, however, not significantly increased for CHCC11379
suggesting that the ability to ferment galactose leads to a
change in composition of the EPS rather than to an
increase in the quantity. In contrast to the results from
Robitaille et al. [36], viscosity and shear stress were
increased when CHCC11379 was used in a yoghurt
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culture together with an EPS positive Lb. delbrueckii ssp.
bulgaricus strain. This indicates that texture in milk is
not determined solely by the amount of excreted EPS;
EPS structure and the interaction between different EPS
types also play a role.
Bacteriophage resistant mutants
Capsular polysaccharides (CPS) can provide a protective
barrier against bacteriophage infection although it was
reported that it was not possible, so far, to increase EPS
production using bacteriophages as selective agent [38].
Nevertheless, we speculated that selecting for bacter-
iophage resistance in CPS positive and, at the same
time, EPS excreting S. thermophilus strains could result
in mutants with increased CPS production and
improved texture. S. thermophilus CHCC11977 was iso-
lated as a bacteriophage-resistant mutant of a galactose-
positive S. thermophilus strain, and its texturizing prop-
erties in milk, measured as shear stress and viscosity,
were improved by 20% compared to its parent [39]. The
amount of excreted EPS was also increased by 20% in
CHCC11977.
Removal of undesirable traits
LABs are used in food fermentations due to their many
desirable properties. However, certain properties may be
undesired in the food chain while others might be undesir-
able under certain conditions. Elimination of an undesir-
able property will be an improvement of the industrial
properties of a strain.
Elimination of antibiotic resistance
The increasing resistance of pathogenic bacteria to com-
monly used antibiotics is a growing threat to public health
[40]. Resistance can either be acquired by mutation or by
the transfer of antibiotic resistance genes from other bac-
teria. Bacteria intentionally added to the food supply
should not contain transmissible antibiotic resistance
genes. For this reason, all strains which are intended for
use in the food chain are tested genotypically [41] and
phenotypically [4] for antibiotic resistances not normally
observed in the relevant species. Strains with atypical pat-
terns are further characterized and those with potentially
transmissible antibiotic resistance genes are either elimi-
nated from further product development or measures are
taken to eliminate or inactivate the undesired antibiotic
resistance determinant.
Transmissible antibiotic resistance genes are often
located on transposable elements or plasmids. While
this increases the likelihood of transfer, it also simplifies
the elimination process since these elements are often
genetically unstable.
Lb. crispatus CHCC3692 contains an erm(B) gene
encoding high level resistance to erythromycin on a 3.2
kb transposon. Heat shock treatment at 60°C was found
to induce the expression of a transposase and resulted
in excision of erm(B) from the chromosome [42].
Plasmids encoding antibiotic resistance genes are com-
mon in lactic acid bacteria and especially in Lactobacil-
lus isolates. A number of different methods exist for
elimination of a plasmid from a strain; the optimal
method being highly strain dependent [43]. Acridine
orange and mitomycin-C were used to eliminate an erm
gene from a strain of Lb. fermentum [44] while novobio-
cin was used to eliminate a tet(M) and a tet(S) gene,
respectively, from two different strains of Lb. plantarum
[45,46]. Protoplast formation and regeneration was the
only method found suitable to remove two plasmids
encoding tetracycline resistance (tet (W)) and lincosa-
mide resistance (lnu(A)) from a commercially used pro-
biotic Lb. reuteri strain [47].
In some cases, it might be of interest to eliminate or
inactivate antibiotic resistance genes which have not been
shown to be transmissible and which do not reside on a
transposon or plasmid. An example of this is the tet(W)
gene responsible for tetracycline resistance in all known
members of Bifidobacterium animalis subsp. lactis [48].
Ultraviolet light mutagenesis of cells grown in the pre-
sence of ethidium bromide was used to obtain tetracy-
cline-sensitive mutants of strains bearing a chromosomal
tet(W) gene. For all mutants tested, it was possible to
obtain strains with mutations in the tet(W) gene [48,49].
Elimination of citrate metabolism
The ability to catabolize citrate to acetate, carbon diox-
ide and pyruvate is present in many LABs, and citrate
utilization is often associated with the production of
acetoin and diacetyl [50]. While these compounds
improve the properties of some fermented products (e.g.
buttermilk and some cheeses), excessive production is
unwanted in others (e.g. wine and cottage cheese).
During malolactic fermentation in wine by Oenococcus
oeni, the accumulation of acetate and diacetyl resulting
from citrate metabolism can negatively impact the sen-
sory properties [51]. Random mutagenesis was used to
eliminate citrate utilization in a commercial O. oeni
strain. The resulting variant contains a nonsense muta-
tion in the citrate transporter gene [4]. The ability to uti-
lize citrate in O. oeni is plasmid encoded [52] suggesting
plasmid curing as an alternative approach as described in
the section describing random mutagenesis.
The ability of L. lactis subsp. lactis biovar diacetylactis
to utilize citrate is also plasmid encoded [53]. This fea-
ture is important for the production of flavor com-
pounds and carbon dioxide in cheeses like Danbo,
Havarti and Gouda, but these compounds are unwanted
for the production of cottage cheese (see also the sec-
tion describing random mutagenesis). Elimination of the
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citrate plasmid in L. lactis subsp. lactis biovar diacety-
lactis can be achieved by heat-shock or treatment with
novobiocin resulting in strains useful for cottage cheese
production [54].
Urease negative mutants of S. thermophilus
Traditionally, cottage cheese is made by fermenting milk
with L. lactis [55]. Recently, the use of S. thermophilus
as a starter cultures for cottage cheese has gained popu-
larity due to its faster acidification rate resulting in a
faster production process in the dairy and a significant
gain in capacity.
S. thermophilus possesses amidohydrolase activity
(urease; EC. 3.5.1.5) which converts urea into ammonia
and carbon dioxide [56]. The carbon dioxide is incorpo-
rated into the cheese curd particles making them float
which hinders whey removal and results in a loss of
cheese mass. To tackle this problem a urease negative
mutant of S. thermophilus CHCC4895 was isolated by
random mutagenesis. Screening was done on plates con-
taining a pH indicator; mutants devoid of urease activity
lack buffering capacity due to reduced ammonia produc-
tion. Mutant CHCC12406 did not show the typical pH
increase when grown in milk with added urea, verifying
the urease negative phenotype (Figure 2), and ammonia
production was reduced by ca. 90%. Cheese trials made
with CHCC12406 showed reduced floating of cheese
curd particles (Figure 3) confirming the role of the S.
thermophilus urease activity in the “floating curd” phe-
nomenon and the possible use of cheese cultures based
on urease negative mutants as a solution [57].
Improving stress tolerance
Industrial production of starter cultures and their subse-
quent use in industrial processes for the production of
fermented food subject the LABs to a large variety of
stresses. For probiotic LABs, there is the additional
stress associated with life in the human gastrointestinal
tract. There is a strong interest in increasing the intrin-
sic tolerance of LABs to these stress factors.
Lactobacillus strains with improved ethanol or bile
tolerance
Malolactic fermentation mediated by LABs is important
for flavor development in a number of wine varieties.
Ethanol levels in wine have been increasing in recent
years, possibly as a consequence of higher sugar levels
in grapes caused by warmer growing seasons, putting
stress on the malolactic bacteria. Consequently, develop-
ment of malolactic bacteria that are resistant to higher
levels of alcohol would be useful in the wine industry.
Adaptation is often used to make microorganisms more
tolerant to environmental stresses but this effect is only
temporary. Resistance, on the other hand, is a perma-
nent property which is typically acquired through
genetic change. During the characterization of Lb. plan-
tarum D-cycloserine resistant mutants, we discovered a
number of unexpected phenotypes. For example, a num-
ber of the mutants are significantly more tolerant to
ethanol than the parent strain. It was postulated that
changes in the cell surface architecture result in reduced
access of ethanol to the cell membrane thereby resulting
in increased ethanol tolerance [58].
When efficacy of a probiotic strain is directly related to
viability in the gastrointestinal tract, strain improvement
can include increasing survival following exposure to gas-
tric acid and bile. Multiple mechanisms are proposed to
account for increased resistance to bile including efflux
of bile acids/salts, modified sugar metabolism, and cell
membrane or cell wall composition modification [59-61].
We also tested mutants of potentially probiotic Lactobacil-
lus strains, selected using D-cycloserine resistance as
described previously, for enhancement of bile tolerance.
Some D-cycloserine resistant mutants showed higher sur-
vival rates than the parental strain when exposed to a bile
shock and others demonstrated additional useful
Figure 2 Acidification curves (dashed line) of S. thermophilus CHCC4895 (A) and its urease mutant CHCC12046 (B) and the effect of
the addition of urea (solid line).
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characteristics such as improved survival following gastric
acid shock or desiccation. Genome sequence analysis
showed unique mutations in each strain, though not all
obviously related to D-cycloserine resistance. Importantly,
for several highly bile tolerant isolates, there were no
detectable changes in other in vitro characteristics used to
evaluate probiotic potential, including adherence to mucus
and stimulation of dendritic cell cytokine secretion.
Acid production
The specific acids and the quantities produced by lactic
acid bacteria in fermented products have major
Figure 3 Small scale cheese trails with strain CHCC4895 and its urease mutant CHCC12406. Differences in the settlement of curd particles
of both strains is illustrated in a 1-liter beaker (A) and small scale cheese vats (B). Left side strain CHCC4895; right side urease mutant
CHCC12406.
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consequences on the properties of the final product.
Acid production by LABs is therefore a desirable prop-
erty to modulate and control.
Lactobacillus strains with low post acidification
Strains of Lb. delbrueckii subsp. bulgaricus and S. ther-
mophilus are essential culture components in the pro-
duction of yoghurt. While many strains of Lb. delbrueckii
subsp. bulgaricus display excellent texturizing properties,
they might not be suitable for mild yoghurt applications
due to the continued production of lactic acid during the
shelf life of the yoghurt, a process referred to as “post-
acidification”. Current consumer preferences for yoghurt
are for mild products with low post-acidification and a
high texture.
A random mutagenesis and screening strategy was
developed [62] to generate Lb. delbrueckii subsp. bulgari-
cus strains that combine excellent texturizing properties
with low-post acidification. A strain with suitable textur-
izing properties but high post-acidification was treated
with a mild mutagen and the resulting strain library
screened in milk in microtiter plates using a colorimetric
method for pH determination [4]. Mutants showing a
higher end-pH than the mother strain were subsequently
screened to find those which retained the desirable tex-
turizing properties. This led to the isolation of a unique
strain of Lb. delbrueckii subsp. bulgaricus, CHCC10019,
which is able to acidify and texturize milk under indust-
rially relevant conditions but is characterized by low post
acidification. When using CHCC10019, the pH of the fer-
mented milk drops by less than 0.20 pH units over 7 days
at 8°C.
In another approach to obtain improved strains with
reduced post-acidification the importance of the oligo-
peptide transport for growth fitness of S. thermophilus
in milk was explored. The oligopeptide transport system
in S. thermophilus consists of a seven proteins (AmiA1,
AmiA2, AmiA3, AmiC, AmiD, AmiE and AmiF) and
mutants exhibiting an altered oligopeptide transport sys-
tem were found to have a reduced acidification rate
[63]. The toxic oligopeptide analog aminopterine is
transported into the cell by the Ami system. Accord-
ingly, Garault et al. isolated Ami-deficient mutants with
reduced post-acidification in milk by selecting for
mutants that were resistant to this analog [64].
Altering acidification properties by adapting
carbohydrate metabolism
When grown in milk, the majority of S. thermophilus
strains take up lactose and excrete galactose via the
galactose-lactose antiporter [65]. In mozzarella cheese
this excreted galactose can lead to “browning” upon
heating of the cheese. This is ascribed to the Maillard
reaction, where galactose, a reducing sugar, reacts with
amino groups from amino acids. In addition, excess free
galactose can lead to post acidification problems and
imbalance in the cheese flora due to growth of resident
lactic acid bacteria. Galactose positive wild type strains
or galactose fermenting mutants are therefore interest-
ing, especially for the purpose of reducing browning in
pizza cheese.
Most strains of S. thermophilus are unable to grow on
galactose as sole carbon source; those that do grow use
the Leloir pathway (Figure 4A). Nearly all strains con-
tain the gal genes, but naturally occurring mutations in
the galK promoter result in poor expression [66].
Screening 49 strains revealed only eight galactose fer-
menters [67] while we found 38 out of 247 S. thermo-
philus strains screened from our culture collection to
have this capability. Since most strains do contain intact
gal genes, it should be possible to isolate galactose posi-
tive variants from them. Mutants can be selected on
M17 plates with galactose as sole carbon source and
characterized by DNA sequencing. For example, the
mutant mentioned in the section describing the optimi-
zation of the metabolic pathway of EPS has a mutation
in the promoter region upstream of galK leading to
increased expression of the gal genes. Similarly, strain
CHCC14993, derived from the fast acidifying strain
CHCC4323, has a G to A transition resulting in an
improved Pribnow box ‘TACAAT’ (Figure 4B). This sin-
gle nucleotide exchange enables CHCC14993 to grow
on galactose and results in an 11% (w/v) reduction in
excreted galactose in milk fermented with this strain.
Increasing the growth yield during fermentation
When LABs are grown in a batch culture, cells with the
fastest growth rate dominate, often at the expense of bio-
mass yield [68]. This is of concern to the starter culture
industry as efficiency in the factory is dependent on
the production of the maximum amount of biomass at the
lowest cost [69]. Using an elegant emulsion system, it was
possible to obtain L. lactis mutants with an increased
growth yield [68] by eliminating the competitive advantage
rapid growth gives in a liquid culture. The yield improve-
ment occurred via mutations which divert the metabolism
from lactate production towards mixed acid fermentation.
Because these mutants cannot ferment lactose and pro-
duce reduced levels of lactate, they are not particularly
useful for the dairy industry. They do, however, illustrate
very nicely the tradeoff between growth rate and biomass
yield that occurs in bacteria and suggest methods for
changing the specific acids produced by a strain.
Lactobacillus helveticus producing succinate
A variety of chemical analogues have been used to isolate
mutants of Lactobacillus with improved flavor formation.
One analogue, 3,4-dehydroproline, was expected to
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generate mutants with altered proline and glutamate
metabolism in Lb. helveticus. However, when the mutants
were characterized, one mutant showed a biphasic acidi-
fication of milk and was found to be unable to produce
succinate. Genome sequencing revealed a single muta-
tion; it was in an L-lactate dehydrogenase (EC 1.1.1.27;
lhe_1813). This finding is consistent with the deviation in
acidification pattern but does not readily explain the
lacking succinate production. Perhaps the L-lactate dehy-
drogenase also serves as a malate dehydrogenase. A strain
defective in malate dehydrogenase will not produce
fumarate and consequently no succinate. However, the
isolation of a lactate/malate dehydrogenase mutant using
3,4-dehydroproline was not expected and cannot be read-
ily explained. This illustrates an added benefit of direct
selection methods and the use of analogs: surprising
observations might lead to new insight into the metabo-
lism of LABs.
Summary and future perspectives
There is a constant need for new strains for inclusion in
starter cultures for the food fermentation industry. New
Figure 4 Galactose and lactose metabolism in S. thermophilus, reproduced from Johansen et al. [3](A). Abbreviations: LacS, lactose
transporter; LacZ, b-galactosidase; GlcK, glucose kinase; GalM, mutarotase; GalK, galactokinase; PGM, a-phosphoglucomutase; GalT, galactose
1-phosphate udridyltransferase; GalE, UDP glucose 4-epimerase; GalU, UDP glucose pyrophosphorylase; gal1P, galactose-1-phosphate; g1p,
glucose-1-phosphate; g6p, glucose-6-phosphate; UDP-glu, UDP-glucose; and UDP-gal, UDP-galactose. (B) The promoter region of the galactose
operon; the mutation in the Pribnow box of the mutant strain in bold and marked (*). The enhanced expression of galK is indicated by a
thickened arrow in the pathway and an arrow in the promoter region of the operon.
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strains can either come from screening of wild-type
strains from natural sources as described by Johansen
et al. [4] or improvement of existing strains as described
herein. Many industrially relevant properties can be
addressed by these techniques. These include: enhance-
ment of bacteriophage resistance; improvement of the
texturizing capability of strains for yoghurt production;
elimination of traits undesirable in any food fermenta-
tion; elimination of traits undesirable in specific food
fermentations; improvement of stress tolerance; and
modulation of both the specific acids produced during
fermentation as well as the amounts produced. Classical
strain improvement can be combined with natural
methods of gene transfer like conjugation, transduction
and natural transformation to create industrial strains
with improved properties in a variety of genetic
backgrounds.
An alternative approach is strain improvement using
established techniques of recombinant DNA technology.
A large number of methods have been developed to create
genetically modified organisms which fulfil a published
definition of ‘food-grade’ [69,70]. These are not currently
used for the direct development of industrial starter
cultures due to concerns over consumer acceptance and
regulatory approval. Recombinant DNA technology is,
however, routinely used in research laboratories for proof-
of-concept and subsequently followed up by the develop-
ment of similar strains created through the use of classical
strain improvement. The advantages and disadvantages of
the various methods of strain improvement are described
in Table 1.
Recent advances in the field of genome editing may
provide additional ways of improving strain perfor-
mance. Technologies like recombineering [71] and use
of the CRISPR-Cas9 system [72] allow for precise modi-
fication, at the single nucleotide level, in a genome of
interest. This allows the production of strains which will
be totally indistinguishable from strains produced by
classical strain improvement. This high level of specifi-
city in genome editing will require a reassessment of
not only the definition of a genetically modified organ-
ism but also the reasons behind discriminating strains
based on the methods used to develop them.
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